Obsessive-compulsive disorder is characterized by the presence of either obsessions or compulsions, but more commonly by both symptoms that can cause marked impairment or distress.
Obsession is a recurrent, persistent, intrusive, unwanted thought, image or urge that cause distressing emotions (eg anxiety and disgust).
Compulsion is a repetitive behavior or mental act that the person feels driven to perform, in order to lessen the distress caused by the obsession.
Anxiety is the central feature of obsessive-compulsive disorder.

Principles of Therapy

  • Both psychotherapy & pharmacotherapy are effective

Goals of Treatment

  • Educate the patient & family about obsessive-compulsive disorder, the symptoms & its treatment
  • Help patient develop coping strategies for stressors
  • Decrease symptom frequency & severity
  • Improve the patient’s functioning & quality of life
  • Enhance patient’s ability to cooperate with care on the face of frightening cognitions caused by obsessive-compulsive disorder
  • Reduce or minimize any drug’s adverse effects to improve treatment compliance
    • Inform the patient about the likely side effects
    • Schedule follow-up to monitor treatment compliance & response

Choice of Treatment

  • Depends on the following factors:
    • Patient’s preference
    • Degree or nature of functional impairment, severity of symptoms
    • Age
    • Patient’s motivation & ability to comply with the treatment modality
    • Presence of comorbidities
    • Cost of treatment

Treatment Setting

  • Provide the least restrictive setting which is safe & effective

Combination Therapy

  • Considered in patients with an unsatisfactory response to monotherapy, with co-occurring psychiatric disorders for which pharmacological therapy are effective, those who want to shorten the duration of medication, & those who have severe obsessive-compulsive disorder
  • Reviews showed that pharmacological therapy yields an early response to treatment, while psychotherapy may likely lead to maintained effects even after treatment discontinuation


  • Pharmacological therapy is recommended in the following patients:
    • Who are uncooperative with or who have inadequate response to cognitive-behavioral therapy
    • Have moderate to severe functional impairment
    • Have good response to a given drug
    • Who prefer pharmacotherapy
  • Symptoms are usually relieved but not completely eliminated
    • There is usually an improvement in quality of life
  • Substantial improvement is experienced 4-6 weeks after initiating therapy; some patients may respond after 10-12 weeks
  • Successful pharmacotherapy should be continued for 1-2 years in adults & 6 months in children & adolescents
  • Gradually taper by decrements of 10-25% every 1-2 months while observing for recurrence of symptoms or exacerbation
  • Many patients relapse once medication is stopped
    • Discontinuation of pharmacotherapy should be considered carefully
    • Continued therapy of some form is recommended for most patients

Selective Serotonin Reuptake Inhibitors (SSRI)

  • Eg Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, & Sertraline are recommended for obsessive-compulsive disorder patients
  • Inhibit the reuptake of serotonin & normalize serotonergic imbalances
    • Different selective serotonin reuptake inhibitors inhibit serotonin reuptake to different extents
  • Provide obsessive-compulsive disorder symptom improvement
  • Selective serotonin reuptake inhibitors are equally effective; however, patient may respond well to one medication & not to another
  • Fluvoxamine & Sertraline are the recommended selective serotonin reuptake inhibitors for children & adolescents
  • Fluoxetine may be used in children with comorbid depression
  • Fluvoxamine, Paroxetine & Sertraline had similar efficacy but with better tolerability compared to Clomipramine
  • May gradually increase dose to maximum if with inadequate response after 4-6 weeks & with no adverse effects
    • Drug dosages used to treat obsessive-compulsive disorder are usually higher than those used to treat depression
  • Monitor closely for adverse effects & suicidal tendencies/self-harm especially during the early phase of therapy & when increasing the dose


  • As effective as selective serotonin reuptake inhibitors, but the selective serotonin reuptake inhibitors are well or better tolerated
  • It has shown benefits not only in adults but also in children & adolescents as well
  • A tricyclic antidepressant; also blocks muscarinic cholinergic receptors, H1 histamine receptors, alpha1- adrenergic receptors & sodium channels
  • Relieves symptoms of obsessive-compulsive disorder
  • Side effects (particularly anticholinergic effects) & potential for fatal overdose may limit its use

Non-Pharmacological Therapy


  • Obsessive-compulsive disorder is a chronic illness with a waxing & waning course
  • Therapy is indicated when symptoms cause significant distress or interfere with functioning
  • Individualize therapy according to the patient’s needs & capacities
  • Establish & maintain a good therapeutic alliance between the physician & patient so that treatment will be more effectively planned & implemented
    • Consider the patient’s feelings & acts toward the physician
    • Consider the patient’s wants & expectations from treatment
    • Provide the patient sufficient time to consider treatment options
  • Assess patient’s symptoms
    • Differentiate the obsessions, compulsions, & rituals of obsessive-compulsive disorder from similar symptoms found in other disorders (eg depression, generalized anxiety disorder, post-traumatic stress disorder, schizophrenia, mania)
  • Perform a complete psychiatric assessment including medical evaluation
  • Use rating scales
    • Perform baseline severity rating of obsessive-compulsive disorder symptoms, comorbidities & their effects on patient’s functioning
  • Ensure safety of the patient & others
  • Guided self-help with support & information for the family members is used for children & adolescents with mild functional impairment
  • Dynamic psychotherapy or psychoanalysis
    • No controlled studies to show the efficacy in dealing with obsessive-compulsive disorder symptoms
    • May still be helpful in patients to overcome their resistance in accepting a recommended therapy by enlightening them on the reasons for wanting to stay as they are
    • Address interpersonal consequences of obsessive-compulsive disorder symptoms
  • Motivational interview
    • May also be useful to overcome resistance to therapy

Cognitive-Behavioral Therapy (CBT)

  • Recommended as 1st-line therapy for children, adolescents & adults with obsessive-compulsive disorder
  • Most widely used psychological therapy
  • Indicated in patients who are not too anxious, depressed, severely ill to cooperate, or who do not prefer pharmacological therapy
    • Used in children & adolescents who have moderate to severe functional impairment & those with mild functional impairment for whom guided self-help has been ineffective or refused
  • Exposure may result in normalization of corticostriatal-thalamic-cortical circuitry
  • Various studies show that behavioral therapy is successful in 50-90% of the patients with obsessive-compulsive disorder
    • The only form of psychotherapy for obsessive-compulsive disorder whose effectiveness is supported by clinical trials
  • Cognitive interventions incorporated into behavioral therapy
  • Eliminates risk of medication side effects & produces results that may be better maintained after medical treatment is terminated
  • Low intensity cognitive-behavioral therapy
    • Used in adult patients with mild functional impairment
    • Includes brief individual cognitive-behavioral therapy using structured self-help materials, brief individual cognitive-behavioral therapy by phone, & group cognitive-behavioral therapy
    • Also includes exposure & response prevention (ERP)
    • Up to 10 therapist hours per patient
  • Intensive Cognitive-Behavioral Therapy
    • Used in adult patients with moderate to severe functional impairment & those who have inadequate response to low intensity cognitive-behavioral therapy
    • Includes exposure & response prevention
    • >10 therapist hours per patient
  • Brief treatment (eg 13-20 weekly sessions)
    • May use daily treatments if speed is of the essence or in severe obsessive-compulsive disorder
  • More severe patients may need longer therapy &/or more frequent sessions
  • Include family members in the treatment process as patient’s behavior may affect the family system, or when family members can support patient treatment, especially if the patient is a child or a young adult
  • Individualize intensity & length of sessions

Exposure & Response Prevention (ERP)

  • Considered the 1st-line psychological treatment approach in obsessive-compulsive disorder
  • Involves gradually exposing patients to stimuli that elicit obsessive fear (eg “contaminated” objects) while simultaneously preventing them from performing any of their compulsive rituals (eg hand washing)
  • Situations that provoke moderate anxiety are done first, followed as quickly as tolerable by exposures of increasing difficulty
  • Patients must confront their fears for a prolonged period without ritualizing to allow the anxiety to dissipate on its own (“habituation”)
  • Aims to weaken the connections between feared stimuli & distress, & between doing the rituals & relief from distress
  • Some data has shown that exposure & response prevention may be more effective when habituation is integrated with discussions of feared consequences & with relapse prevention
  • Successful exposure & response prevention should be followed by monthly booster sessions for 3-6 months, or more intensively if there is only partial response to treatment
  • Efficacy has been demonstrated in children & adolescents, although the literature is smaller compared to adults

Cognitive Therapy

  • Helps patients identify & modify thought patterns that cause anxiety, distress, or negative behavior

Combination of Exposure & Response Behavioral & Cognitive Therapy

  • Integration of exposures with discussions of dysfunctional beliefs & feared consequences is likely to be the most effective psychotherapy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
4 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
13 Jun 2019
Response to desmopressin treatment for nocturnal enuresis in children appears to be compromised in the presence of constipation, particularly in children with severe enuresis and those prescribed low doses, as reported in a recent study.
14 Jun 2019
Elevated serum urate concentrations may be protective against dementia, regardless of subtype, reports a recent study.